Skip to main content
Gomekli 1 mg/1 tablet, for suspension by SpringWorks Therapeutics, Inc.
Gomekli, 1 mg/1, tablet, for suspension Drug class: Kinase Inhibitor. Available on prescription only. Listed by SpringWorks Therapeutics, Inc..
Prescription only

Gomekli

mirdametinib

Listed by SpringWorks Therapeutics, Inc.

Strength
1 mg/1
Form
Tablet, For Suspension
Route
Oral
Class
Kinase Inhibitor

What it contains

  • Mirdametinib 1 mg/1

FDA record

Dosage form Tablet, For Suspension
Route Oral
Drug class Kinase Inhibitor
Approval route NDA — original brand approval
NDC code 82448-134
FDA application NDA219379
Package sizes listed 2
Marketed since February 2025

Other products containing Mirdametinib

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Gomekli

mirdametinib

Strength
1 mg/1
Form
Capsule
Class
Kinase Inhibitor
Rx only

SpringWorks Therapeutics, Inc.

Not stocked by us — reference only

Gomekli

mirdametinib

Strength
2 mg/1
Form
Capsule
Class
Kinase Inhibitor
Rx only

SpringWorks Therapeutics, Inc.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.